By Michele Maatouk
Date: Tuesday 06 Jan 2026
(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.
By Frank Prenesti
Date: Monday 22 Sep 2025
(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.
By Michele Maatouk
Date: Tuesday 16 May 2023
(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.
| Currency | US Dollars |
| Share Price | $ 336.29 |
| Change Today | $ 6.70 |
| % Change | 2.03 % |
| 52 Week High | $387.62 |
| 52 Week Low | $262.28 |
| Volume | 3,119,091 |
| Shares Issued | 538.80m |
| Market Cap | $181,193m |
| Beta | 0.02 |
| RiskGrade | 100 |
| Strong Buy | 7 |
| Buy | 8 |
| Neutral | 14 |
| Sell | 2 |
| Strong Sell | 1 |
| Total | 32 |

| Time | Volume / Share Price |
| 16:00 | 186 @ $336.22 |
| 15:59 | 382 @ $336.29 |
| 15:59 | 40 @ $336.27 |
| 15:59 | 40 @ $336.27 |
| 15:59 | 58 @ $336.25 |
You are here: research